par Burris, Howard A;Awada, Ahmad ;Kuhn, Josée ;Eckardt, J R;Cobb, P W;Rinaldi, D A;Fields, S;Smith, L;Von Hoff, D D
Référence Anti-cancer drugs, 5, 4, page (394-402)
Publication Publié, 1994-08
Référence Anti-cancer drugs, 5, 4, page (394-402)
Publication Publié, 1994-08
Article révisé par les pairs
Titre: |
|
Auteur: | Burris, Howard A; Awada, Ahmad; Kuhn, Josée; Eckardt, J R; Cobb, P W; Rinaldi, D A; Fields, S; Smith, L; Von Hoff, D D |
Informations sur la publication: | Anti-cancer drugs, 5, 4, page (394-402) |
Statut de publication: | Publié, 1994-08 |
Sujet CREF: | Sciences bio-médicales et agricoles |
MeSH keywords: | Adult |
Aged | |
Antineoplastic Agents -- adverse effects | |
Antineoplastic Agents -- pharmacokinetics | |
Antineoplastic Agents -- therapeutic use | |
Camptothecin -- adverse effects | |
Camptothecin -- analogs & derivatives | |
Camptothecin -- pharmacokinetics | |
Camptothecin -- therapeutic use | |
Dose-Response Relationship, Drug | |
Drug Administration Schedule | |
Female | |
Humans | |
Infusions, Intravenous | |
Male | |
Middle Aged | |
Neoplasms -- drug therapy | |
Neoplasms -- metabolism | |
Topotecan | |
Note générale: | Clinical Trial |
Clinical Trial, Phase I | |
Journal Article | |
Langue: | Anglais |
Identificateurs: | urn:issn:0959-4973 |
info:pmid/7949242 |